Conclusion of Ulticare® Promotion by Mantra Pharma Inc.

Effective December 15, 2025, Mantra Pharma Inc. will no longer be responsible for promoting Ulticare® products on behalf of Stericycle Inc.

BROSSARD, March 17, 2025 – Myriad Pharma, the division of Mantra Pharma specializing in the marketing of over-the-counter products, is expanding its representation network with two new partners: Laboratoire Modilac and La ligne J'ARRÊTE.

BROSSARD, January 20, 2025 – Mantra Pharma, a leading Quebec-based developer and marketer of generic medications, announces the upcoming launch of M-METFORMIN, an addition to its generic range.

Brossard, November 7, 2023 – Mantra Pharma, a company that develops and markets generic drugs and over-the-counter products, has taken another step to achieve its growth objectives by signing an agreement to bring in Marcan Pharmaceuticals, a Canadian pharmaceutical company, as a shareholder.

BROSSARD, 21 September, 2022 - Since the beginning of 2022, Mantra Pharma has launched several new products, planning to offer no less than six new molecules by December, one of which is M-Apixaban. The Quebec-based pharmaceutical company is ready for a very busy fall and has increased its portfolio to nearly 100 products.

LÉVIS, 10 January, 2021 - It is with great pride that Mantra Pharma’s Lévis team opened its new warehouse and business location The building already spreads out over 35,000 square feet and hosts 25 employees.